Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits

References

• NormanRJDewaillyDLegroRSHickeyTEPolycystic ovary syndromeLancet2007370958868569717720020
   PubMed Web of Science ®Google Scholar
• MeloASVieiraCSBarbieriMAHigh prevalence of polycystic ovary syndrome in women born small for gestational ageHum Reprod20102582124213120573680
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM—Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Hum Reprod2004191414714688154
   PubMed Web of Science ®Google Scholar
• VrbikovaJCibulaDCombined oral contraceptives in the treatment of polycystic ovary syndromeHum Reprod Update200511327729115790599
   PubMed Web of Science ®Google Scholar
• FauserBCTarlatzisBCRebarRWConsensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertil Steril20129712838.e2522153789
   PubMed Web of Science ®Google Scholar
• GoodmanNFCobinRHFutterweitWGlueckJSLegroRSCarminaEAmerican Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome – part 1Endocr Pract201521111291130026509855
   PubMed Web of Science ®Google Scholar
• YildizBOApproach to the patient: contraception in women with polycystic ovary syndromeJ Clin Endocrinol Metab2015100379480225701301
   PubMed Web of Science ®Google Scholar
• EhrmannDAPolycystic ovary syndromeN Engl J Med2005352121223123615788499
   PubMed Web of Science ®Google Scholar
• NaderSDiamanti-KandarakisEPolycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesisHum Reprod200722231732217099212
   PubMed Web of Science ®Google Scholar
• EltingMWKorsenTJBezemerPDSchoemakerJPrevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS populationHum Reprod200116355656011228228
   PubMed Web of Science ®Google Scholar
• AzzizRWoodsKSReynaRKeyTJKnochenhauerESYildizBOThe prevalence and features of the polycystic ovary syndrome in an unselected populationJ Clin Endocrinol Metabol200489627452749
   PubMed Web of Science ®Google Scholar
• MoranLJMissoMLWildRANormanRJImpaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201016434736320159883
   PubMed Web of Science ®Google Scholar
• World Health OrganizationMedical Eligibility Criteria for Contraceptive Use5th edGenevaWorld Health Organization2015 Available from: http://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/
   Google Scholar
• Escobar-MorrealeHFCarminaEDewaillyDEpidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome SocietyHum Reprod Update201218214617022064667
   PubMed Web of Science ®Google Scholar
• CharitidouCFarmakiotisDZournatziVThe administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndromeAtherosclerosis2008196295896517418849
   PubMed Web of Science ®Google Scholar
• ZimmermanYEijkemansMJCoelingh BenninkHJBlankensteinMAFauserBCThe effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysisHum Reprod Update20142017610524082040
   PubMed Web of Science ®Google Scholar
• BhattacharyaSMJhaAComparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndromeFertil Steril20129841053105922795636
   PubMed Web of Science ®Google Scholar
• ConwayGDewaillyDDiamanti-KandarakisEESE PCOS Special Interest GroupThe polycystic ovary syndrome: a position statement from the European Society of EndocrinologyEur J Endocrinol20141714P12924849517
   PubMed Web of Science ®Google Scholar
• Merki-FeldGSImthurnBRosselliMSpanausKImplanon use lowers plasma concentrations of high-molecular-weight adiponectinFertil Steril2011951232720576266
   PubMed Web of Science ®Google Scholar
• BarryJAAziziaMMHardimanPJRisk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201420574875824688118
   PubMed Web of Science ®Google Scholar
• CibulaDGompelAMueckAOHormonal contraception and risk of cancerHum Reprod Update201016663165020543200
   PubMed Web of Science ®Google Scholar
• BahamondesLBahamondesVMShulmanLPNon-contraceptive benefits of hormonal and intrauterine reversible contraceptive methodsHum Reprod Update201521564065126037216
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIDanielsSRDiagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific StatementCirculation2005112172735275216157765
   PubMed Web of Science ®Google Scholar
• ChenMJYangWSYangJHRelationship between androgen levels and blood pressure in young women with polycystic ovary syndromeHypertension20074961442144717389259
   PubMed Web of Science ®Google Scholar
• YilmazMBukanNErsoyRChenCLHoHNYangYSGlucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndromeHum Reprod20052092414242015890734
   PubMed Web of Science ®Google Scholar
• OelkersWKEffects of estrogens and progestogens on the renin-aldosterone system and blood pressureSteroids19966141661718732994
   PubMed Web of Science ®Google Scholar
• ChenWSrinivasanSRLiSBoerwinkleEBerensonGSGender-specific influence of NO synthase gene on blood pressure since childhood: the Bogalusa Heart StudyHypertension200444566867315466663
   PubMed Web of Science ®Google Scholar
• OelkersWDrospirenone, a progestogen with antimineralocorticoid properties: a short reviewMol Cell Endocrinol20042171–225526115134826
   PubMed Web of Science ®Google Scholar
• Sitruk-WareRNew progestagens for contraceptive useHum Reprod Update200612216917816291771
   PubMed Web of Science ®Google Scholar
• PalaciosSFoidartJMGenazzaniARAdvances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonismMaturitas200655429730716949774
   PubMed Web of Science ®Google Scholar
• de NadaiMNNobreFFerrianiRAVieiraCSEffects of two contraceptives containing drospirenone on blood pressure in normotensive women: a randomized-controlled trialBlood Press Monit201520631031526154851
   PubMed Web of Science ®Google Scholar
• CurtisKMMohllajeeAPMartinsSLPetersonHBCombined oral contraceptive use among women with hypertension: a systematic reviewContraception200673217918816413848
   PubMed Web of Science ®Google Scholar
• WilsonESCruickshankJMcMasterMWeirRJA prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogenBr J Obstet Gynaecol19849112125412606440589
   PubMedGoogle Scholar
• Chasan-TaberLWillettWCMansonJEProspective study of oral contraceptives and hypertension among women in the United StatesCirculation19969434834898759093
   PubMed Web of Science ®Google Scholar
• LubiancaJNFaccinCSFuchsFDOral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive womenContraception2003671192412521653
   PubMed Web of Science ®Google Scholar
• LubiancaJNMoreiraLBGusMFuchsFDStopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertensionJ Hum Hypertens200519645145515759027
   PubMed Web of Science ®Google Scholar
• BattagliaCManciniFFabbriRPolycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot studyFertil Steril20109441417142519591981
   PubMed Web of Science ®Google Scholar
• MastorakosGKoliopoulosCCreatsasGAndrogen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptivesFertil Steril200277591992712009344
   PubMed Web of Science ®Google Scholar
• GuazzelliCABarreirosFABarbosaRTorloniMRBarbieriMExtended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolismContraception201285438939322067754
   PubMed Web of Science ®Google Scholar
• Morin-PapunenLMartikainenHMcCarthyMIComparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general populationAm J Obstet Gynecol20081995529.e11018533124
   PubMed Web of Science ®Google Scholar
• VieiraCSMartinsWPFernandesJBThe effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndromeContraception201286326827522464410
   PubMed Web of Science ®Google Scholar
• BerneisKRizzoMLazzariniVFruzzettiFCarminaEAtherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndromeJ Clin Endocrinol Metab200792118618917062762
   PubMed Web of Science ®Google Scholar
• GodslandIFBiology: risk factor modification by OCs and HRT lipids and lipoproteinsMaturitas200447429930315063483
   PubMed Web of Science ®Google Scholar
• BarkfeldtJVirkkunenADiebenTThe effects of two progestogen-only pills containing either desogestrel (75 microg/day) or levonorgestrel (30 microg/day) on lipid metabolismContraception200164529529911777489
   PubMed Web of Science ®Google Scholar
• BerensonABRahmanMWilkinsonGEffect of injectable and oral contraceptives on serum lipidsObstet Gynecol2009114478679419888036
   PubMed Web of Science ®Google Scholar
• HalperinIJKumarSSStroupDFLaredoSEThe association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studiesHum Reprod201126119120121059754
   PubMed Web of Science ®Google Scholar
• DragomanMCurtisKMGaffieldMECombined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomesContraception Epub2015810
   Web of Science ®Google Scholar
• SilvaRCPardiniDPKaterCEPolycystic ovary syndrome, metabolic syndrome, cardiovascular risk and the role of insulin sensitizing agentsArq Bras Endocrinol Metabol200650228129016767294
   PubMedGoogle Scholar
• MeloASDiasSVCavalli RdeCPathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopauseReproduction20151501R112425835506
   PubMed Web of Science ®Google Scholar
• PhillipsNDuffyTOne-hour glucose tolerance in relation to the use of contraceptive drugsAm J Obstet Gynecol19731161911004697175
   PubMed Web of Science ®Google Scholar
• KalkhoffRKEffects of oral contraceptive agents on carbohydrate metabolismJ Steroid Biochem1975669499561100908
   PubMedGoogle Scholar
• LopezLMGrimesDASchulzKFSteroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitusCochrane Database Syst Rev20144CD006133
   Google Scholar
• CostelloMFShresthaBEdenJMetformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane reviewHum Reprod20072251200120917261574
   PubMed Web of Science ®Google Scholar
• GalloMFLopezLMGrimesDACarayonFSchulzKFHelmerhorstFMCombination contraceptives: effects on weightCochrane Database Syst Rev20141CD003987
   Google Scholar
• VrbikovaJHainerVObesity and polycystic ovary syndromeObes Facts200921263520054201
   PubMed Web of Science ®Google Scholar
• MoreauCClelandKTrussellJContraceptive discontinuation attributed to method dissatisfaction in the United StatesContraception200776426727217900435
   PubMed Web of Science ®Google Scholar
• KarlssonRLindénAvon SchoultzBSuppression of 24-hour cholecystokinin secretion by oral contraceptivesAm J Obstet Gynecol1992167158591442956
   PubMed Web of Science ®Google Scholar
• ModestoWde Nazaré Silva dos SantosPCorreiaVMBorgesLBahamondesLWeight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of useEur J Contracept Reprod Health Care2015201576325160484
   PubMed Web of Science ®Google Scholar
• LopezLMEdelmanAChenMOtternessCTrussellJHelmerhorstFMProgestin-only contraceptives: effects on weightCochrane Database Syst Rev20137CD008815
   Google Scholar
• GlintborgDAltinokMLMummHHermannAPRavnPAndersenMBody composition is improved during 12 months’ treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndromeJ Clin Endocrinol Metab20149972584259124742124
   PubMed Web of Science ®Google Scholar
• GlintborgDMummHAltinokMLRichelsenBBruunJMAndersenMAdiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndromeJ Endocrinol Invest201437875776424906976
   PubMed Web of Science ®Google Scholar
• DomecqJPPrutskyGMullanRJAdverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysisJ Clin Endocrinol Metab201398124646465424092830
   PubMed Web of Science ®Google Scholar
• GlueckCJPapannaRWangPGoldenbergNSieve-SmithLIncidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndromeMetabolism200352790891512870169
   PubMed Web of Science ®Google Scholar
• ApridonidzeTEssahPAIuornoMJNestlerJEPrevalence and characteristics of metabolic syndrome in women with polycystic ovary syndromeJ Clin Endocrinol Metab20059041929193515623819
   PubMed Web of Science ®Google Scholar
• CarminaENapoliNLongoRARiniGBLoboRAMetabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOSEur J Endocrinol2006154114114516382003
   PubMed Web of Science ®Google Scholar
• GuoMChenZJMacklonNSCardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteriaReprod Biomed Online201021457258020800551
   PubMed Web of Science ®Google Scholar
• MeloASVieiraCSRomanoLGFerrianiRANavarroPAThe frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenismReprod Sci201118121230123622096008
   PubMed Web of Science ®Google Scholar
• YildizBOBozdagGYapiciZEsinlerIYaraliHPrevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteriaHum Reprod201227103067307322777527
   PubMed Web of Science ®Google Scholar
• WiltgenDSpritzerPMVariation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypesFertil Steril20109462493249620338557
   PubMed Web of Science ®Google Scholar
• BirdSTHartzemaAGBrophyJMEtminanMDelaneyJARisk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysisCMAJ20131852E115E12023209115
   PubMed Web of Science ®Google Scholar
• de GrootPCDekkersOMRomijnJADiebenSWHelmerhorstFMPCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysisHum Reprod Update201117449550021335359
   PubMed Web of Science ®Google Scholar
• AndersonSABarryJAHardimanPJRisk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysisInt J Cardiol2014176248648725096551
   PubMed Web of Science ®Google Scholar
• RoachREHelmerhorstFMLijferingWMStijnenTAlgraADekkersOMCombined oral contraceptives: the risk of myocardial infarction and ischemic strokeCochrane Database Syst Rev20158CD011054
   Google Scholar
• LidegaardØLøkkegaardEJensenASkovlundCWKeidingNThrombotic stroke and myocardial infarction with hormonal contraceptionN Engl J Med2012366242257226622693997
   PubMed Web of Science ®Google Scholar
• LidegaardØNielsenLHSkovlundCWSkjeldestadFELøkkegaardERisk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9BMJ2011343d642322027398
   PubMed Web of Science ®Google Scholar
• DingerJBardenheuerKHeinemannKCardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral ContraceptivesContraception201489425326324576793
   PubMed Web of Science ®Google Scholar
• de BastosMStegemanBHRosendaalFRCombined oral contraceptives: venous thrombosisCochrane Database Syst Rev20143CD010813
   Google Scholar
• ManthaSKarpRRaghavanVTerrinNBauerKAZwickerJIAssessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysisBMJ2012345e494422872710
   PubMed Web of Science ®Google Scholar
• PompERle CessieSRosendaalFRDoggenCJRisk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutationsBr J Haematol2007139228929617897305
   PubMed Web of Science ®Google Scholar
• WuORobertsonLTwaddleSScreening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) studyHealth Technol Assess200610111110
   PubMed Web of Science ®Google Scholar